SCHEMBL5264271

SCHEMBL5264271

Cn1c(CCBr)c(Cl)c(=O)n1-c1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
MITF O75030 1/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
FPR2 P25090 2/20 0.33
BRD4 O60885 1/20 0.33
KAT2B Q92831 1/20 0.33
BPTF Q12830 1/20 0.33
ALDH1A1 P00352 2/20 0.32
NPBWR1 P48145 1/20 0.32
MAPT P10636 3/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
THRB P10828 1/20 0.32
GAA P10253 1/20 0.32
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4325141 0.88 MEN1 (0.38) MEN1KMT2ANPSR1MITFPKM
SCHEMBL4319898 0.85 BCHE (0.43) MEN1KMT2AFPR2ALDH1A1THRB
SCHEMBL8259595 0.84 FPR2 (0.41) MEN1KMT2ANPSR1MITFPKM
SCHEMBL5266592 0.82 NPBWR1 (0.40) ALDH1A1NPBWR1L3MBTL1
SCHEMBL4334363 0.76 FPR2 (0.41) MEN1KMT2ANPSR1HTTRAB9A
SCHEMBL4318702 0.75 KMT2A (0.51) MEN1KMT2ARAB9AFPR2ALDH1A1
SCHEMBL4335745 0.73 FPR2 (0.38) HTTRAB9AFPR2ALDH1A1NPBWR1
SCHEMBL4326568 0.73 BRD9 (0.44) MEN1KMT2AHTTKAT2BALDH1A1
SCHEMBL4321221 0.73 BCHE (0.45) MEN1KMT2AFPR2ALDH1A1THRB
SCHEMBL4318895 0.72 KMT2A (0.43) MEN1KMT2ANPSR1MITFPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833800-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS AstraZeneca AB (SE) 2007-09-19 EP disclosed
EP-1812439-A2 KINASE INHIBITORS Takeda San Diego, Inc. (US) 2007-08-01 EP disclosed
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed
WO-2006044687-A2 KINASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2006-04-27 WO disclosed